Global Anti-PD-1 MAb Sales Market Report 2021

1 Anti-PD-1 MAb Market Overview

• 1.1 Anti-PD-1 MAb Product Scope
• 1.2 Anti-PD-1 MAb Segment by Type
  • 1.2.1 Global Anti-PD-1 MAb Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 40mg
  • 1.2.3 100mg
  • 1.2.4 200mg
  • 1.2.5 Others
• 1.3 Anti-PD-1 MAb Segment by Application
  • 1.3.1 Global Anti-PD-1 MAb Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Melanoma Patients
  • 1.3.3 Lung Cancer Patients
  • 1.3.4 Lymphoma Patients
  • 1.3.5 Other
• 1.4 Anti-PD-1 MAb Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Anti-PD-1 MAb Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Anti-PD-1 MAb Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Anti-PD-1 MAb Price Trends (2016-2027)

2 Anti-PD-1 MAb Estimates and Forecasts by Region

• 2.1 Global Anti-PD-1 MAb Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Anti-PD-1 MAb Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Anti-PD-1 MAb Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Anti-PD-1 MAb Revenue Market Share by Region (2016-2021)
• 2.3 Global Anti-PD-1 MAb Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Anti-PD-1 MAb Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Anti-PD-1 MAb Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Anti-PD-1 MAb Estimates and Projections (2016-2027)
  • 2.4.2 Europe Anti-PD-1 MAb Estimates and Projections (2016-2027)
  • 2.4.3 China Anti-PD-1 MAb Estimates and Projections (2016-2027)
  • 2.4.4 Japan Anti-PD-1 MAb Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Anti-PD-1 MAb Estimates and Projections (2016-2027)
  • 2.4.6 India Anti-PD-1 MAb Estimates and Projections (2016-2027)

3 Global Anti-PD-1 MAb Competition Landscape by Players

• 3.1 Global Top Anti-PD-1 MAb Players by Sales (2016-2021)
• 3.2 Global Top Anti-PD-1 MAb Players by Revenue (2016-2021)
• 3.3 Global Anti-PD-1 MAb Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-PD-1 MAb as of 2020)
• 3.4 Global Anti-PD-1 MAb Average Price by Company (2016-2021)
• 3.5 Manufacturers Anti-PD-1 MAb Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Anti-PD-1 MAb Market Size by Type

• 4.1 Global Anti-PD-1 MAb Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Anti-PD-1 MAb Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Anti-PD-1 MAb Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Anti-PD-1 MAb Price by Type (2016-2021)
• 4.2 Global Anti-PD-1 MAb Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Anti-PD-1 MAb Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Anti-PD-1 MAb Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Anti-PD-1 MAb Price Forecast by Type (2022-2027)

5 Global Anti-PD-1 MAb Market Size by Application

• 5.1 Global Anti-PD-1 MAb Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Anti-PD-1 MAb Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Anti-PD-1 MAb Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Anti-PD-1 MAb Price by Application (2016-2021)
• 5.2 Global Anti-PD-1 MAb Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Anti-PD-1 MAb Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Anti-PD-1 MAb Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Anti-PD-1 MAb Price Forecast by Application (2022-2027)

6 North America Anti-PD-1 MAb Market Facts & Figures

• 6.1 North America Anti-PD-1 MAb Sales by Company
  • 6.1.1 North America Anti-PD-1 MAb Sales by Company (2016-2021)
  • 6.1.2 North America Anti-PD-1 MAb Revenue by Company (2016-2021)
• 6.2 North America Anti-PD-1 MAb Sales Breakdown by Type
  • 6.2.1 North America Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
• 6.3 North America Anti-PD-1 MAb Sales Breakdown by Application
  • 6.3.1 North America Anti-PD-1 MAb Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Anti-PD-1 MAb Sales Breakdown by Application (2022-2027)

7 Europe Anti-PD-1 MAb Market Facts & Figures

• 7.1 Europe Anti-PD-1 MAb Sales by Company
  • 7.1.1 Europe Anti-PD-1 MAb Sales by Company (2016-2021)
  • 7.1.2 Europe Anti-PD-1 MAb Revenue by Company (2016-2021)
• 7.2 Europe Anti-PD-1 MAb Sales Breakdown by Type
  • 7.2.1 Europe Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
• 7.3 Europe Anti-PD-1 MAb Sales Breakdown by Application
  • 7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)

8 China Anti-PD-1 MAb Market Facts & Figures

• 8.1 China Anti-PD-1 MAb Sales by Company
  • 8.1.1 China Anti-PD-1 MAb Sales by Company (2016-2021)
  • 8.1.2 China Anti-PD-1 MAb Revenue by Company (2016-2021)
• 8.2 China Anti-PD-1 MAb Sales Breakdown by Type
  • 8.2.1 China Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
• 8.3 China Anti-PD-1 MAb Sales Breakdown by Application
  • 8.3.1 China 241 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 241 Sales Breakdown by Application (2022-2027)

9 Japan Anti-PD-1 MAb Market Facts & Figures

• 9.1 Japan Anti-PD-1 MAb Sales by Company
  • 9.1.1 Japan Anti-PD-1 MAb Sales by Company (2016-2021)
  • 9.1.2 Japan Anti-PD-1 MAb Revenue by Company (2016-2021)
• 9.2 Japan Anti-PD-1 MAb Sales Breakdown by Type
  • 9.2.1 Japan Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
• 9.3 Japan Anti-PD-1 MAb Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Anti-PD-1 MAb Market Facts & Figures

• 10.1 Southeast Asia Anti-PD-1 MAb Sales by Company
  • 10.1.1 Southeast Asia Anti-PD-1 MAb Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Anti-PD-1 MAb Revenue by Company (2016-2021)
• 10.2 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type
  • 10.2.1 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Anti-PD-1 MAb Sales Breakdown by Application
  • 10.3.1 Southeast Asia KG Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia KG Sales Breakdown by Application (2022-2027)

11 India Anti-PD-1 MAb Market Facts & Figures

• 11.1 India Anti-PD-1 MAb Sales by Company
  • 11.1.1 India Anti-PD-1 MAb Sales by Company (2016-2021)
  • 11.1.2 India Anti-PD-1 MAb Revenue by Company (2016-2021)
• 11.2 India Anti-PD-1 MAb Sales Breakdown by Type
  • 11.2.1 India Anti-PD-1 MAb Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Anti-PD-1 MAb Sales Breakdown by Type (2022-2027)
• 11.3 India Anti-PD-1 MAb Sales Breakdown by Application
  • 11.3.1 India Anti-PD-1 MAb Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Anti-PD-1 MAb Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Anti-PD-1 MAb Business

• 12.1 Bristol Myers Squibb
  • 12.1.1 Bristol Myers Squibb Corporation Information
  • 12.1.2 Bristol Myers Squibb Business Overview
  • 12.1.3 Bristol Myers Squibb Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Bristol Myers Squibb Anti-PD-1 MAb Products Offered
  • 12.1.5 Bristol Myers Squibb Recent Development
• 12.2 Merck
  • 12.2.1 Merck Corporation Information
  • 12.2.2 Merck Business Overview
  • 12.2.3 Merck Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Merck Anti-PD-1 MAb Products Offered
  • 12.2.5 Merck Recent Development
• 12.3 Junshi Pharma
  • 12.3.1 Junshi Pharma Corporation Information
  • 12.3.2 Junshi Pharma Business Overview
  • 12.3.3 Junshi Pharma Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Junshi Pharma Anti-PD-1 MAb Products Offered
  • 12.3.5 Junshi Pharma Recent Development
• 12.4 Innovent Biologics Inc
  • 12.4.1 Innovent Biologics Inc Corporation Information
  • 12.4.2 Innovent Biologics Inc Business Overview
  • 12.4.3 Innovent Biologics Inc Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Innovent Biologics Inc Anti-PD-1 MAb Products Offered
  • 12.4.5 Innovent Biologics Inc Recent Development
• 12.5 Hengrui Medicine
  • 12.5.1 Hengrui Medicine Corporation Information
  • 12.5.2 Hengrui Medicine Business Overview
  • 12.5.3 Hengrui Medicine Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Hengrui Medicine Anti-PD-1 MAb Products Offered
  • 12.5.5 Hengrui Medicine Recent Development
• 12.6 Beijing Beigene
  • 12.6.1 Beijing Beigene Corporation Information
  • 12.6.2 Beijing Beigene Business Overview
  • 12.6.3 Beijing Beigene Anti-PD-1 MAb Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Beijing Beigene Anti-PD-1 MAb Products Offered
  • 12.6.5 Beijing Beigene Recent Development

...

13 Anti-PD-1 MAb Manufacturing Cost Analysis

• 13.1 Anti-PD-1 MAb Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Anti-PD-1 MAb
• 13.4 Anti-PD-1 MAb Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Anti-PD-1 MAb Distributors List
• 14.3 Anti-PD-1 MAb Customers

15 Market Dynamics

• 15.1 Anti-PD-1 MAb Market Trends
• 15.2 Anti-PD-1 MAb Drivers
• 15.3 Anti-PD-1 MAb Market Challenges
• 15.4 Anti-PD-1 MAb Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List